该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ 美东时间 2016-11-04 09:00 Before Open:CAMBREX CORP Earning Release . Wall St EPS Est ($):0.41. 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2016-10-31 AccNo: 0001437749-16-040553 Size: 39 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01: Financial S...
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2016-07-28 AccNo: 0001437749-16-035816 Size: 495 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$凯姆布雷克斯(CBM)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-07-28 AccNo: 0001437749-16-035811 Size: 4 MB 网页链接
$凯姆布雷克斯(CBM)$ 内部交易: 2016-07-11,Director,KORB WILLIAM B ,卖出,3420普通股, $55.00
$凯姆布雷克斯(CBM)$ 内部交易: 2016-07-11,Director,KORB WILLIAM B ,期权,3420普通股, $41.22
$凯姆布雷克斯(CBM)$ 美东时间 2016-06-10 10:00 Cambrex Corp at Jefferies Healthcare Conference 网页链接
$凯姆布雷克斯(CBM)$ 8-K - Current report Filed: 2016-05-23 AccNo: 0001437749-16-032607 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 1.02: Termination of a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation...
$凯姆布雷克斯(CBM)$ 美东时间 2016-05-23 09:30 Cambrex Corp at UBS Global Healthcare Conference 网页链接
$凯姆布雷克斯(CBM)$ 美东时间 2016-05-23 09:30 Cambrex Corp at UBS Global Healthcare Conference 网页链接